TraderT123 schreef op 19 maart 2020 10:45:
Dit is wat er staat :
OpGen Inc. agreed to merge with Germany-based healthcare equipment company Curetis NV in a stock-for-stock transaction.
Under the agreement, OpGen will issue 2,662,564 new common shares to acquire all shares of Curetis. The combined company will be based in Gaithersburg, Md., and will be listed on the Nasdaq as a molecular diagnostics and bioinformatics franchise.
Curetis shareholders will own about 72.5% of OpGen, while OpGen shareholders will own about 27.5% after the issue of new shares.